πŸ‡ΊπŸ‡Έ FDA
Patent

US 12036211

Nicorandil derivatives

granted A61KA61K31/4425A61K31/4545

Quick answer

US patent 12036211 (Nicorandil derivatives) held by UNICYCIVE THERAPEUTICS, INC. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNICYCIVE THERAPEUTICS, INC.
Grant date
Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4425, A61K31/4545, A61K31/455, A61P